The main diagnostic tools used to look for evidence of prostate cancer include digital rectal examination (DRE), serum concentration of prostate-specific antigen (PSA), and transrectal ultrasonography (TRUS)-guided biopsy [2]. In this chapter, we review the clinical role for TRUS and recent ultrasonography developments in the detection and diagnosis of prostate disease.